SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001640455-21-000113
Filing Date
2021-06-22
Accepted
2021-06-22 16:49:06
Documents
2
Period of Report
2021-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162439492194258.html 4  
1 FORM 4 wf-form4_162439492194258.xml 4 4193
2 EXHIBIT 24 - KAMEN LIMITED POWER OF ATTORNEY ex-24.htm EX-24 4364
  Complete submission text file 0001640455-21-000113.txt   9932
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Issuer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O JOUNCE THERAPEUTICS, INC. 1030 MASSACHUSETTS AVENUE BOSTON MA 02210
Business Address
Kamen Robert (Reporting) CIK: 0001693540 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37998 | Film No.: 211035953